Gene Therapy Using Anti-CEA Cells to Treat Metastatic Cancer
Anti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma Patients
|3||Active, not recruiting||
CAR T Cell Receptor Immunotherapy for Patients With B-cell Lymphoma
Lymphodepletion and Anti-PD-1 Blockade to Reduce Relapse in AML Patient Not Eligible for Transplant
† Study has passed its completion date and status has not been verified in more than two years.